When.com Web Search

  1. Ads

    related to: amlodipine 5 mg mylan

Search results

  1. Results From The WOW.Com Content Network
  2. Amlodipine - Wikipedia

    en.wikipedia.org/wiki/Amlodipine

    Amlodipine works partly by vasodilation (relaxing the arteries and increasing their diameter). [10] It is a long-acting calcium channel blocker of the dihydropyridine type. [10] Amlodipine was patented in 1982, and approved for medical use in 1990. [12] It is on the World Health Organization's List of Essential Medicines. [13]

  3. Amlodipine/olmesartan - Wikipedia

    en.wikipedia.org/wiki/Amlodipine/olmesartan

    Amlodipine/olmesartan, sold under the brand name Azor, among others is a fixed-dose combination medication used to treat high blood pressure. [5] It contains amlodipine , as the besilate, a dihydropyridine calcium channel blocker , and olmesartan medoxomil , an angiotensin II receptor blocker .

  4. Amlodipine/valsartan - Wikipedia

    en.wikipedia.org/wiki/Amlodipine/valsartan

    Amlodipine/valsartan, sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains amlodipine , as the besilate, a dihydropyridine -type calcium channel blocker , and valsartan , an angiotensin II receptor antagonist . [ 6 ]

  5. Indapamide - Wikipedia

    en.wikipedia.org/wiki/Indapamide

    Indapamide is a thiazide-like diuretic [4] drug used in the treatment of hypertension, as well as decompensated heart failure.Combination preparations with perindopril (an ACE inhibitor antihypertensive) are available.

  6. Levamlodipine - Wikipedia

    en.wikipedia.org/wiki/Levamlodipine

    In pooled data, from three comparative studies conducted in 200 patients with mild to moderate hypertension, 2.5 mg of levamlodipine was found to be equivalent in its blood pressure lowering efficacy to 5 mg of amlodipine. The average reduction in systolic BP was 19±3 vs 19±4, 20±2 vs 19±3 and 20±2 vs 19±3 mm of Hg recorded in standing ...

  7. Why Mylan NV.’s (NASDAQ:MYL) ROE Of 5.44% Does Not ... - AOL

    www.aol.com/news/why-mylan-nv-nasdaq-myl...

    Mylan NV.’s (NASDAQ:MYL) most recent return on equity was a substandard 5.44% relative to its industry performance of 12.26% over the past year. MYL’s results could indicate a relatively ...

  1. Ad

    related to: amlodipine 5 mg mylan